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INTRODUCTION
Sleepiness at the wheel is a major cause of motor vehicle ac-
cidents (MVAs).1,2 Obstructive sleep apnea (OSA) is associated 
with excessive daytime sleepiness (EDS)3 and cognitive im-
pairment4–6 related to repetitive hypoxia and sleep fragmenta-
tion.4 EDS in OSA has been related to increased accident risk.7
A recent meta-analysis identified an elevated MVA risk 
ratio of 2.43 (95% confidence interval [CI] 1.21–4.89).8 How-
ever, investigations of OSA and risk of MVA are hampered 
by a lack of objectively assessed MVA data and noncompa-
rable methods or recruitment bias.7,9–11 Uncertainty and recall 
bias may also reduce accuracy in terms of MVA classification. 
Furthermore, most studies failed to adjust for traffic exposure, 
defined as driving distance and time period,12–14 which repre-
sent strong confounders in studies of MVA risk. A recent meta-
analysis15 including several studies14,16–19 found that continuous 
positive airway pressure (CPAP) treatment reduced MVA 
risk by 72% (risk ratio of 0.28, 95% CI 0.22–0.35). However, 
limitations in terms of study design, power, incomplete CPAP 
compliance data, and/or reported MVA data reliability were 
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identified. Only two smaller studies were based on objective 
MVA data.14,17
In order to overcome limitations in previous studies, we 
addressed a large, well-characterized patient cohort referred 
for OSA investigation. MVA incidence among these patients 
and a large control population from driver’s license holders in 
the general population was obtained from the Swedish Traffic 
Accident Data Acquisition (STRADA) registry.20 We hypoth-
esized that accident rate is increased in patients with suspected 
OSA compared with the control population, that adequate treat-
ment of the condition will reduce risk, and that specific clinical 
features in patients with OSA may be used to predict risk.
METHODS
The study was approved by the regional ethical review board 
in Gothenburg, Sweden. Patients provided written informed 
consent in association with an overnight diagnostic sleep study 
in the University Hospital.
Patient Population
An unselected sample of 1,718 consecutive clinical patients 
(age 18–80 y) referred for suspected OSA was included in the 
Gothenburg cohort of the multicenter European Sleep Apnea 
Database (ESADA)21 study during the period 2007 to 2011 
(flow chart 1). Participation in the ESADA study was on a vol-
untary basis and approximately 65.4% (n = 1,718) of all referred 
patients agreed to participate. Reported data included anthro-
pometry, co-morbidity, smoking (yes/no) and alcohol habits 
(units/w), driver’s license status (A/B, C/D/E, yes/no), driving 
distance (km/y), subjective sleepiness (Epworth Sleepiness 
Scale22 [ESS]), habitual sleep time, and results from objective 
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cardiorespiratory polygraphy recording (apnea-hypopnea 
index [AHI] and oxygen desaturation index [ODI]).23 Data on 
license holding were missing in 46 cases and 194 patients were 
not license holders, leaving 1,478 license holders for the final 
analysis.
The STRADA Registry and the Control Population
The control population (n = 21,118) included individuals 
from the general population reported in the STRADA reg-
istry.20 Individuals from the general population with a record 
of at least one MVA during the period 2002 to 2012 and with 
distribution of community of residency proportional to that of 
the patient population were included. The registry contains 
information on individual road traffic injuries and accidents 
from the entire Swedish national road transport system.20 The 
information is reported by the Swedish police and the major 
emergency hospitals nationwide. The police at the site of the 
accident collected standardized information for registration 
in the STRADA. All types of accidents, including those in-
volving pedestrians, bicycles, and trains/trams, are reported in 
the registry. The reported information includes geographical 
location, severity and cause of accident, type of accident, and 
degree of personal and property damage.
In this study, information on sex and age of the drivers 
holding a driver’s license, and geographical location of the ac-
cident were acquired. All driver’s license holders (n = 635,786) 
in the general population of the nine residential areas corre-
sponding to the main hospital capture area were identified. 
Within this population we identified 21,118 drivers with an 
MVA record in the STRADA registry during the period 2002 
to 2012. The estimation of the MVA risk was further stratified 
for existing regional driver’s license (A/B or C/D/E) statistics 
provided by the Swedish transportation agency.20
Identification of Motor Vehicle Accidents among Patients
Driver’s license holders (n = 1,478) in the clinical patient 
cohort were cross-analyzed with the STRADA registry. Po-
lice-reported MVAs in the time period between 2002 and 2012 
were addressed. An observation period starting 5 y prior to the 
sleep diagnostic test and up to 5 y thereafter was evaluated. 
Investigators from the university hospital were blinded with 
respect to identity of patients in the STRADA database.
Assessment of OSA
All patients underwent a cardiorespiratory polygraphy re-
cording (PG, Embletta X10 Portable Digital System, Embla 
CO, USA) during sleep according to clinical routine.23 The 
recording included nasal pressure cannula, abdominal and 
thoracic respiratory effort belts, oximetry, body position, and 
recording time. Apneic and hypopneic events were scored 
when minimum event duration of 10 sec was found. Apnea-
hypopnea index (AHI) was defined as the number of apneas/
hypopneas during the recording session defined by lights off 
and lights on. Hypopnea, measured by the nasal cannula, was 
scored either when a ≥ 50% reduction of airflow followed by 
a ≥ 3% oxygen desaturation or a ≥ 30% reduction of airflow 
followed by a ≥ 4% oxygen desaturation was recorded.24 AHI 
was explored both as a continuous and a categorical (mild/mod-
erate/severe OSA according to AHI cutoffs of 5 ≤ 15, 15 ≤ 30 
and ≥ 30 events/h, respectively) variable in the analysis. In the 
risk analysis, all patients undergoing a sleep diagnostic assess-
ment, independent of outcome, were included in the analysis. 
Individuals with an AHI < 5 events/h were not considered as 
healthy controls.
CPAP and Compliance
CPAP prevents upper airway collapse25 in OSA and was 
applied according to clinical routines (autoadjusting positive 
airway pressure (PAP), fixed-pressure PAP, or bilevel PAP in 
85.5, 13.4, and 1.1% of cases, respectively). Information on 
CPAP usage time (h/night) was obtained from the device at 
follow-up visits and a CPAP use of ≥ 4 h/night was considered 
adequate compliance with therapy.26 Individuals with limited 
CPAP use (< 4 h/night) or those who returned CPAP were clas-
sified as insufficiently compliant with therapy in the analysis. 
A mean follow-up time was calculated for each patient based 
on the event of diagnosis during the period 2007 to 2012.
In the current study, patients (n = 1,478) from the ESADA 
registry were cross-analyzed with police-reported informa-
tion in the STRADA registry specifying a history of an MVA 
during a period of 5 y prior to and up to 5 y after the diagnostic 
sleep test. Information collected from the STRADA, included 
community of residency, sex, and age of the driver.
Statistics
MVA risk was calculated in R version 2.15.2 (© 2012, The 
R Foundation for Statistical Computing). All other statistics 
were calculated in PASW Statistics 17.0.2 (SPSS Inc. Chicago, 
IL, USA).
Data are presented as mean (standard deviation) and/or me-
dian [interquartile range], and a two-tailed P < 0.05 was con-
sidered statistically significant.
Analysis Comparing Motor Vehicle Accidents Risk in Patients 
Assessed for OSA and Control Population
Patients from the main hospital capture area, consisting of 
nine different residential regions, with a history of MVAs were 
stratified according to age (18–19, 20–24, 25–34, 35–44, 45–
54, 55–64, 65–74, and ≥ 75–80 y) and calendar year (2002 to 
2012) cohorts. The estimated risk analysis included 74 patients 
with a positive MVA history. Traffic accidents other than MVA 
were excluded (Figure 1).
In order to estimate the MVA rate in the control population, 
we assumed for each calendar year and age (cross-classified) 
stratum that (1) the driver’s license status in the patient cohort 
did not change over time, and (2) that the number of driver’s 
licenses (n = 635,786) in the different age categories were con-
stant. For this assumption we used driver’s license statistics 
from the calendar year 2012 and this was slightly nonconser-
vative. However, sensitivity analyses of an increased number 
of driver’s licenses from 2002 to 2012 did not differ from our 
estimated MVA risk. Realistic figures resulted in one or two ad-
ditional accidents. Some of the accidents in the hospital capture 
area involved drivers residing outside the region, which in a 
conservative way makes risk estimates smaller. Conversely, ap-
proximately 10% of MVAs, caused by drivers living in the nine 
residential areas, occurred outside the study region. For each 
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the patient cohort was multiplied with the estimated proportion 
of MVAs in the control population and the number of driver’s 
license holders in that region. This was interpreted as an esti-
mate of the expected number of MVAs in the patient cohort for 
that specific stratum given that there is no increased risk, and 
conditionally on the number of accidents in that stratum.
Finally, we summed all these expectations over the strata 
and used the actual number of MVAs in the patient cohort in 
all strata as a test variable. Under the null hypothesis assump-
tion of no risk change, this test variable may be argued to be 
roughly Poisson distributed, conditional on all the total MVA 
figures in all the strata, with the sum of the aforementioned ex-
pectations, as its expectation. We used a one-sided test based 
on this Poisson approximation.
The null hypothesis was rejected if the number of observed 
MVAs in the patient cohort was found to be larger than the 
95% quantile of a Poisson distribution, having the estimated 
expected number of MVAs in the control group as its param-
eter. Similarly, additional analyses were performed on MVAs 
in the patient cohort before and/or after sleep diagnostic test. 
Furthermore, we analyzed the observed numbers divided by 
the expected numbers under the null hypothesis, which may 
be interpreted as rough risk estimations of risk ratios. Figure 2 
illustrates the estimated risk analysis. The observed number of 
accidents in the patient group was compared with the estimated 
number in the cross-classified control population. The accidents 
for patients and controls were categorized into three age groups 
accumulated and weighted by each stratum size (Figure 2).
Analysis of Risk Factors for Motor Vehicle Accidents in the 
Patient Cohort
The risk factor analysis included all clinical patients with 
suspected OSA with an MVA (n = 82) and without (n = 1,347) 
any type of traffic accident (TA), irrespective of residency and 
the geographic location of the accident. Nonparametric inde-
pendent samples Mann-Whitney U test and Pearson chi-square 
were used for ordinal or quantitative data and for comparison 
of between group differences (Tables 1 and 2). Binary logistic 
regression was used for categorical response variable and inde-
pendent categorical and continuous predictors (Table 3). Step-
wise backward/forward likelihood ratio methods were used to 
test each predictor for the best model fit and adjusted for the 
year of diagnosis. Variables with a large continuous scale (e.g., 
driving distance) were standardized (z-score) in the analysis, 
but the unstandardized data were reported in order to facilitate 
meaningful interpretation. The time window for CPAP com-
pliance was calculated from the number of follow-up days for 
each patient entering the study (2007 to 2012). The incidence 
of MVA/1,000 individuals/y was calculated before (2002 to 
2007) and after CPAP.
RESULTS
Patient Population
The analysis included 1,478 patients (males 70.4%, mean age 
53.6 (12.8) y, BMI 29.2 (5.5) kg/m2, ESS score 10.6 (5.2) and 
median AHI 17.9 [3.2–24.2] events/h. Driver’s license type A/B 
was reported by 84.2%, and 15.8% had a C/D/E license. A total 
of 82 MVAs were registered in the patient group and subse-
quently censored for this cohort (Figure 1). Of these, 56 MVAs 
occurred before diagnosis and 26 after diagnosis (Figure 1). 
Within the 5-y time period prior to the diagnostic sleep study, 
eight patients had two accidents and one patient had triple ac-
cidents. In the binary logistic regression analysis, only the most 
Figure 1—Study flow chart. ESADA, European Sleep Apnea Database; 
MVA, motor vehicle accident; STRADA, Swedish Traffic Accident Data 
Acquisition registry.
No traffic accident, 
n = 1,347
Traffic accidents with 
actual driver, n = 131
Other accidents than 
MVA or outside the 
time window, n = 49
MVA within time 
period 2002–2012, 
n = 82
MVA after diagnostic 
procedure, n = 26
MVA within 5 years 
before diagnostic 
procedure, n = 56
Gothenburg ESADA cohort, n = 1,718
No driver’s license, 
n = 194
Missing license status, 
n = 46
Driver’s license, n = 1,478
Figure 2—Observed number of accidents in the patient group compared 
with the expected number based on the control group, categorized into 
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recent MVA was used. Patients with multiple accidents were 
younger than those with a single MVA (mean age 41.6 (11.6) and 
51.3 (14.8), respectively, P = 0.06). No differences were found 
with regard to BMI (kg/m2), AHI and ODI (events/h), ESS 
score, driving distance (km/y) or sex (all P ≥ 0.2).
Analysis Comparing Motor Vehicle Accidents Risk in Patients 
Assessed for OSA and Control Population
The estimated risk, calculated as the ratio between the ob-
served and expected number of MVAs, both before and after 
diagnosis, as well as the total number of MVAs was between 
2.3 to 2.6 times higher among patients compared with the con-
trol population (Table 4), adjusted for age, calendar year, and 
driver’s license type. The observed estimated risk for MVA 
decreased gradually between the age groups 18–44, 45–64, 
and 65–80 y (Figure 2). But the strongest relative influence 
of OSA on MVA risk was found in the oldest age group (ratio 
2.42, 2.37, and 3.50, respectively). The sex distribution was 
similar among patients with MVAs and the control population 
(male/female 75.6/24.4% and 70.6/29.4% respectively, P = 0.3).
The odds ratio for MVA-related injury in patients compared 
with the control population was 1.9 (95% CI 1.18–3.18, P < 0.01) 
after adjustment for age, year of accident, and sex.
The Motor Vehicle Accidents Risk Analysis in the Patient 
Cohort
Risk factors for MVA were evaluated among patients with a 
history of MVA and compared with patients without a history 









BD vs. no TA,
AD vs. no TA
Anthropometry
Sex (male), % 75.9 76.9 69.7 ≥ 0.3
Age, y 52.1 (14.5) 46.1 (14.5) 54.0 (12.7) BD 0.5, AD 0.002
BMI, kg/m2 30.0 (5.7) 30.0 (5.8) 29.0 (5.5) ≥ 0.2
OSA and Sleepiness
AHI, n/h a 18.3 (20.5)
11.6 [3.2 to 24.3]
16.7 (19.9)
8.2 [3.6 to 20.9]
17.9 (20.9)
10.4 [3.2 to 24.7]
≥ 0.8
ODI, n/h a 16.9 (18.8)
10.5 [3.3 to 24.6]
14.5 (17.6)
6.8 [4.3 to 18.8]
17.0 (20.2)
10.4 [3.2 to 24.2]
≥ 0.7
Hab. sleep time, h a 7.4 (1.5) 7.3(1.8) 7.5 (1.3) ≥ 0.6
Hab. sleep time ≤ 5 h, % 7.1 15.4 4.2 BD 0.3, AD < 0.01
Hab. sleep latency, min a 32.6 (37.1)
30.0 [10.0 to 30.0]
37.8 (32.5)
30.0 [15.0 to 60.0]
31.9 (34.0)
20.0 [10.0 to 45.0]
≥ 0.2
ESS score 12.2 (5.5) 10.8 (5.1) 10.5 (5.1) BD 0.02, AD 0.8
ESS ≥ 16 31.6 23.1 18.1 BD 0.01, AD 0.5
Comorbidity and Medication 
DM, % 17.2 11.5 10.1 ≥ 0.08
CVD, % 39.7 42.3 46.2 ≥ 0.3
Psychiatric disorder, % a 14.0 7.1 10.7 0.7
Hypnotic med. (ATC-N05), % 17.2 11.5 10.7 ≥ 0.1
Psychoanaleptic med. (ATC-N06), % 19.3 3.8 17.1 ≥ 0.07
Lifestyle Habits
Alcohol consumption, units/w a 5.9 (10.4)
3.0 [0.0 to 7.2]
6.1 (6.2)
5.0 [1.0 to 9.0]
5.8 (7.9)
3.0 [0.0 to 8.0]
≥ 0.5
Smoking, % 19.6 19.2 14.9 ≥ 0.3
Driving Habits
Kilometers driven, 1,000/y a 26.0 (34)
15.0 [10 to 30]
26.0 (22)
20.0 [15 to 30]
18.0 (21)
15.0 [8 to 20]
BD 0.3, AD 0.001
C/D/E license, % 15.5 15.4 15.7 ≥ 0.9
Statistics: Data are presented as mean (standard deviation) and/or median [range]. P ≤ 0.05 was considered significant. a Data completeness ≥ 83%. 
AD, after diagnostic sleep test; AHI, apnea-hypopnea index; ATC, anatomical therapeutic chemical classification; BD, before diagnostic sleep test; CVD, 
cardiovascular disease; DM, diabetes mellitus; ESS, Epworth Sleepiness Scale; Hab., habitual; MVA, motor vehicle accident; ODI, oxygen desaturation 
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Table 2—Baseline characteristics and motor vehicle accidents for patients with and without continuous positive airway pressure compliance.
CPAP ≥ 4 h/night
(n = 263)




Sex (male), % 77.9 72.4 0.1
Age, y 57.1 (10.5) 56.4 (11.6) 0.8
BMI, kg/m2 30.6 (5.3) 29.5 (5.4) 0.02
Sleepiness and OSA
Habitual sleep latency, minutes 23.3 (24.8)
15.0 [5.0 to 30.0]
32.1 (33.7)
25.0 [10.0 to 45.0]
0.002
Hab. sleep time, h 7.5 (1.2) 7.4 (1.4) 0.2
ESS score 11.6 (5.0) 10.7 (5.2) 0.02
AHI, n/h 30.2 (23.7)
23.4 [11.9 to 43.5]
22.3 (22.1)
14.9 [6.9 to 29.3]
 < 0.001
CPAP usage, h/night 5.8 (1.3) 1.4 (1.5)  < 0.001
Comorbidity and Medication
DM, % 16.3 13.5 0.3
CVD, % 60.1 55.6 0.3
Psychiatric disorder, % 9.8 11.2 0.6
Insomnia, % 0.4 2.0 0.09
Hypnotic med. (ATC-N05), % 7.6 10.5 0.2
Psychoanaleptic med. (ATC-N06), % 17.9 13.5 0.1
Lifestyle
Smoking, % 12.5 16.4 0.2
Alcohol consumption ≥ 10 units/w 5.8 (6.7)
5.0 [1.0 to 8.0]
6.2 (7.1)
4.0 [0.0 to 9.7]
0.9
Driving Habits
DL (CDE), % 19.4 18.1 0.7
MVA, n (%) 3.0 (1.2) 13.0 (4.4)  < 0.02
Kilometers driven, 1,000/y 20.0 (20)
15.0 [10 to 25]
18.0 (22)
15.0 [5 to 20]
0.002
Statistics: chi-square, data are presented as mean (standard deviation) and/or median [range], P ≤ 0.05 was considered significant. AHI, apnea-hypopnea 
index; ATC, anatomical therapeutic chemical classification; CPAP, continuous positive airway pressure; CVD, cardiovascular disease; DL, driver’s license; 
DM, diabetes mellitus; ESS, Epworth Sleepiness Scale; Hab., habitual; km, kilometers; MVA, motor vehicle accident.
Table 3—Independent predictors associated with motor vehicle accidents among patients with obstructive sleep apnea – results from the multivariable 
regression analysis.
Estimate (SE) OR 95% CI for OR P
Age, y −0.019 (0.010) 0.98 0.962 to 1.000 0.05
Hab. sleep time ≤ 5 h 0.96 (0.43) 2.66 1.14 to 6.01 0.02
ESS score ≥ 16 0.76 (0.27) 2.13 1.26 to 3.61 0.005
Hypnotic use 0.73 (0.33) 2.07 1.07 to 3.98 0.03
Driving distance, 10,000 km/y 0.085 (0.04) 1.09 1.01 to 1.18 0.03
Sex (male) 0.33 (0.30) 1.42 0.78 to 2.45 0.2
DL type, (C/D/E) −0.04 (0.35) 0.92 0.536 to 2.02 0.9
Diagnosis y −0.13 (0.09) 0.88 0.74 to 1.05 0.9
Constant 251.0 (179.0) 0.2
R2 = 0.05 (Hosmer and Lemeshow), 0.07 (Nagelkerke). Model chi-square = 30.7, P < 0.001. P < 0.05 was considered significant. CI, confidence interval; 
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of any type of traffic accident (Table 1). Patients with an 
MVA before diagnosis had a higher ESS score, whereas those 
with an MVA after diagnosis were younger, more frequently 
reported a short subjective sleep time (≤ 5 h/night), less fre-
quently psychoanaleptic drug users, and had longer driving 
distances (Table 1). Sex, BMI, and prevalence of comorbidities 
did not differ between groups (Table 1). Variables describing 
severity of the OSA condition (AHI, ODI) were similar in all 
groups (all P ≥ 0.3).
In the logistic regression analysis, short sleep duration, se-
vere EDS (ESS ≥ 16), and use of hypnotic drugs all indepen-
dently provided more than 2.0-fold increased odds for an MVA 
(Table 3). Young age and elevated driving distance were asso-
ciated with 2% and 9% higher odds for an MVA, respectively 
(Table 3). No associations were found between MVA and sex 
or driver’s license type (Table 3).
Patients (n = 567) with available CPAP treatment data had 
a mean follow-up time of 3.5 (1.0) y. However, 38% of the 
patients returned their CPAP (CPAP off), 15.5% used CPAP 
with low compliance (< 4 h/night), and 46.5% were highly 
compliant CPAP users (≥ 4 h/night). Median CPAP compli-
ance was 0.0 (0.0 to 2.0), 2.0 (1.0 to 3.0), and 6.0 (5.0 to 7.0) 
h/night, respectively. The number of MVAs among patients 
in whom OSA had been diagnosed without information on 
treatment (n = 462) was reduced by 62% (9.5–4.0 incidence of 
MVA/1,000 individuals/y) following diagnosis.
The MVA incidence was reduced by 70.0% among patients 
with high CPAP (≥ 4 h/night) compliance, whereas it increased 
by 54.0% among noncompliant patients (< 4 h/night or off 
CPAP) (Figure 3). During the corresponding time window 
from 2007 to 2012, there was an observed decrease of acci-
dents by 15.9% in the STRADA. Patients with high compli-
ance had fewer MVAs, a higher AHI, BMI, ESS score, and 
annual driving distance at the time of diagnosis compared 
with the low compliance group (Table 2). No group differences 
were found at baseline with respect to sex, age, comorbidity, 
and smoking and alcohol consumption (Table 2).
DISCUSSION
This large-scale retrospective cohort study using national 
traffic accident statistics provides strong evidence for a link 
between sleep apnea and traffic safety. Patients with OSA had 
more frequent MVAs, and injury following the accidents was 
more common when compared with the control population. Ef-
fectively used CPAP therapy was associated with a reduction 
of MVA frequency. Severe daytime sleepiness, but not severity 
of sleep apnea, was identified as a risk factor for MVA in pa-
tients with OSA.
The current study found a 2.5-fold increased MVA risk in 
patients with OSA, which is in line with previous findings.8 
Our data extend current knowledge in several aspects. First, 
our MVA reports are based on high-quality, objectively re-
ported accident information by police officers at the scene. 
Questionnaire-based reports on MVAs are generally consid-
ered as of limited confidence.8,14 Moreover, current data on 
objective MVA reports may be limited because of the inconsis-
tent source of information (police/insurance company/driver) 
and the variable format of accident reports.2,16 For example, 
Findley et al.14 used a governmental registry containing data 
provided by the driver involved in the accident and/or the state 
police. Second, we only included accidents where the subject 
was the actual driver involved in the MVA. Third, our study 
is the largest so far to be based on objective MVA data and 
classification of personal injury related to the accident. Finally, 
national accident statistics suggest that the influence of OSA 
on traffic safety may be particularly well studied in the realm 
of the current statistics. Sweden is, in terms of traffic safety 
standards, considered as a leading country and the reported 
MVA-related death rate is the lowest in Europe (28/106 inhabit-
ants compared to European mean of 68/106 during 2010).27 It 
may therefore be speculated that the effect of OSA on MVA 
frequency and injury rate may be even higher in other areas of 
Europe or the world.
The predictors of increased MVA risk in patients with OSA 
remain unclear and generate a challenge in clinical medicine. 
OSA severity (e.g., AHI or ODI) appear to only poorly predict 
Figure 3—Incidence of motor vehicle accidents (MVAs) per 1,000 
individuals per year before and after continuous positive airway pressure 
(CPAP) intervention. Statistics: * 70% reduction, ** 54% increase.
Table 4—The expected number of motor vehicle accidents used as a parameter of a Poisson distribution. 
Expected MVA, n 95% Quantile Observed MVA, n Observed/Expected P
Before diagnosis 19.14 27 49 2.56 2.48 E−09
After diagnosis 11.04 17 25 2.26 7.35 E−05
Total 30.19 39 74 2.45 3.30 E−12
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actual crash risk, and our findings were in line with previous 
reports suggesting that risk of accident is complex to predict 
on an individual basis in patients with sleep apnea. Subjec-
tively assessed EDS has been shown to be associated with 
self-reports of near-miss crash rates.28 Objective assessment of 
daytime sleepiness by the Multiple Sleep Latency Test (MSLT) 
or the Maintenance of Wakefulness Test (MWT)4 have been 
proposed as reliable predictors of MVA risk among patients 
with hypersomnia.29 However, these methods produced 
conflicting data in a study of patients with sleep disordered 
breathing.12 However, we identified several additional factors 
previously shown to associate with MVA risk, such as severe 
subjective daytime sleepiness (ESS score ≥ 16), long annual 
driving distance,30 use of hypnotic medication,31 young age,1,32 
and short self-reported sleep time.30 Not only would there be a 
high degree of interaction between these risk factors, it is also 
likely that they are not sufficiently specific for the condition 
of sleep apnea alone. For instance, frequent driving is linked 
to shortened sleep time,30 younger individuals are known to 
experience daytime sleepiness irrespective of sleep apnea,3 
shortened sleep time is associated with increased degree of 
sleepiness,33 and hypnotic medication use may induce com-
promised alertness and performance deficits in driving tests.31 
Other potential confounders accounted for in our study, but not 
shown to influence MVA risk, included diabetes, alcohol, body 
composition measures, psychotropic medication, insomnia di-
agnosis, and sex. Future medicolegal regulations on driving in 
sleep apnea therefore need to jointly address the interaction 
between the condition and its treatment, the driver, and the 
circumstances of driving in a more general perspective.
CPAP is highly effective in eliminating sleep apnea thereby 
improving sleep quality and overnight oxygenation. Conse-
quently, therapy is expected to result in improved daytime 
alertness and better driving performance. In addition, aware-
ness of an OSA diagnosis and interaction with a professional 
health care environment is highly likely to increase awareness 
of the risk of sleepy driving.
Findley et al.14 assessed the number of automobile accidents 
before and after successful treatment with nasal CPAP. Crash 
rate was eliminated after CPAP but remained unchanged in 
patients with untreated OSA.14 However, this was a small 
study and CPAP compliance was determined by a telephone 
interview. Another study conducted by George et al.17 found a 
threefold higher MVA ratio (0.18 versus 0.06 crashes/driver/y) 
based on collision reports in untreated patients. This risk was 
normalized following CPAP.17 However, information on the 
type of accident and objective CPAP compliance was not pro-
vided. Other studies of the CPAP effect consistently lack ob-
jective assessment of MVA frequency.16,34
In a recent meta-analysis conducted by Tregear et al.,15 nine 
retrospective studies evaluating the effect of CPAP on MVA 
risk were examined.11,14,16–19,34–36 Only two of the nine studies 
were controlled and based on objective MVA data.14,17 The 
overall MVA risk reduction in patients with severe OSA was 
65–78% following CPAP (risk ratio 0.278, mean 0.22–0.35, 
P < 0.01).15 In addition, our data show, for the first time, that 
MVA risk reduction is confined to patients who comply with 
therapy for at least 4 h/night. This threshold effect of CPAP 
therapy has been reported for blood pressure treatment in 
patients with hypertension37 as well as in a study addressing 
subjective and objective measures of daytime alertness.26 
Somewhat unexpectedly we found that patients with lower 
CPAP compliance paradoxically had an increased MVA fre-
quency, suggesting that incomplete CPAP use is linked to 
high traffic accident risk. The most likely explanation for this 
finding is that noncompliant patients, in terms of lifestyle, con-
stitute a group that is less health focused and more risk prone. 
This finding, however, would remain as speculation because 
we were unable to identify markers of an unhealthy lifestyle, 
including nicotine/alcohol consumption, obesity, and/or spe-
cific comorbidities, in the noncompliant group. In fact, driving 
exposure was even lower among these patients. Interestingly, 
sleep latency was significantly increased in the noncompliant 
CPAP group, a finding that potentially may reflect an influence 
of comorbid insomnia.38
Our study adds to the field because it controlled for several 
factors of importance for the association between sleep apnea 
and traffic accidents including objective and standardized 
MVA characterization, stratification of residency and driver’s 
license type, traffic exposure, nationwide coverage of MVA re-
ports, phenotyping of OSA severity and risk factors for sleepy 
driving, assessment of treatment compliance by means of ob-
jective CPAP-log data, and a large sample size.
Despite these strengths, some study limitations need to be 
mentioned. The current study addresses a clinical sleep apnea 
cohort. It cannot be excluded that patients with OSA seeking 
medical attention to a higher extent may represent individuals 
who previously have experienced sleepiness behind the wheel, 
a near-miss accident, or even an actual MVA. Data therefore 
may not be generally extrapolated to the general effect of sleep 
apnea on traffic safety. However, the MVA frequency was 
evenly distributed throughout the years and did not accumu-
late directly prior to the referral for sleep testing. We lacked 
detailed information on type and effectiveness of treatment in 
a subgroup of 462 patients. It is assumed that most of these 
patients received therapy in line with conventional routines. 
Nevertheless, we found a reduced incidence of MVAs in this 
group suggesting that, in addition to the overall background re-
duction of MVAs during the period 2002–2012, there appeared 
to be an effect of intervention that unfortunately escaped de-
tection because of incompleteness of data. Furthermore, data 
on actual annual driving distance and degree of daytime sleep-
iness in the general population subsample is incomplete. To 
control for traffic density and exposure to traffic, the patient 
cohort as well as the control population were stratified for age, 
geographic region based on the hospital capture area, and in-
formation on driver’s license type. It is noted that the accident 
rate in this study, approximately 0.002, is substantially lower 
than that reported in previous studies (0.02, 0.07, 0.08).2,14,34 
Possible explanations include statistics showing a substantial 
reduction of MVA during the past decade, the high national 
traffic safety standards, and most importantly the proportion-
ally stricter criteria for an MVA definition applied. Finally, ex-
cessive sleepiness was defined by means of the ESS. Because 
the ESS is a subjective measure, it is prone to recall bias and 
a systematic underestimation particularly among commercial 
drivers. Therefore, these factors are likely to increase variance 
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exploratory risk factor analysis suggests the need for further 
data collection, in particular concerning the role of CPAP 
compliance.
CONCLUSION
Our study provides strong evidence that untreated OSA in-
creases the risk of MVA and this is influenced by severe day-
time sleepiness. Apnea events do not predict MVA risk but 
OSA treatment with CPAP leads to considerable risk reduction. 
Identification of MVA risk prone individuals remains to be a 
challenge in the management of patients with OSA. Impor-
tantly, patients using CPAP who are not in compliance may re-
quire specific attention in the clinical assessment of MVA risk.
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SUPPLEMENTAL MATERIAL
Table S1—Characteristics of the general control population obtained from the Swedish traffic accident data acquisition registry (STRADA) stratified by 
age and calendar year.
Age Class N
Age (y) 
mean (SD) Sex, (male, %)
All 18–19 878 18.6 (0.5) 73.1
20–24 2,703 21.9 (1.4) 73.7
25–34 4,722 29.6 (2.9) 69.4
35–44 4,936 39.5 (2.9) 67.8
45–54 3,841 49.2 (2.9) 71.5
55–64 2,641 59.1 (2.8) 72.4
65–74 1,021 68.8 (2.9) 71.2
75–80 376 77.3 (1.7) 72.1
Total 18–80 21,118 40.5 (14.8) 70.6
2002 18–19 76 18.7 (0.5) 84.2
20–24 277 21.8 (1.4) 76.2
25–34 514 29.5 (2.9) 73.7
35–44 537 39.2 (2.9) 69.8
45–54 344 49.2 (3.0) 71.8
55–64 267 58.7 (2.8) 72.7
65–74 87 68.9 (2.9) 69.0
75–80 42 77.4 (1.8) 81.0
2003 18–19 84 18.6 (0.5) 75.0
20–24 304 21.9 (1.4) 78.9
25–34 509 29.8 (2.9) 68.4
35–44 519 39.3 (2.8) 70.1
45–54 376 49.4 (3.0) 71.8
55–64 284 59.1 (2.8) 75.4
65–74 92 68.9 (2.8) 72.8
75–80 42 77.3 (1.8) 85.7
2004 18–19 104 18.6 (0.5) 72.1
20–24 302 21.8 (1.4) 73.8
25–34 480 29.4 (2.8) 72.3
35–44 504 39.5 (2.9) 67.1
45–54 353 49.0 (2.9) 72.8
55–64 244 59.1 (2.7) 77.9
65–74 85 68.6 (2.8) 82.4
75–80 35 77.4 (1.7) 62.9
2005 18–19 83 18.5 (0.5) 69.9
20–24 270 22.3 (1.4) 73.0
25–34 504 29.6 (2.8) 71.2
35–44 520 39.2 (2.8) 67.7
45–54 354 49.2 (2.9) 70.3
55–64 259 59.0 (2.9) 70.7
65–74 80 69.2 (3.0) 76.3
75–80 34 77.9 (1.6) 61.8
2006 18–19 99 18.6 (0.5) 73.7
20–24 315 22.0 (1.4) 74.6
25–34 525 29.5 (3.0) 64.0
35–44 503 39.6 (2.9) 68.4
45–54 377 49.4 (2.8) 73.2
55–64 251 59.0 (2.8) 69.7
65–74 103 69.2 (3.1) 74.8
75–80 44 76.7 (1.6) 70.5
Age Class N
Age (y) 
mean (SD) Sex, (male, %)
2007 18–19 94 18.6 (0.5) 70.2
20–24 275 22.0 (1.4) 73.8
25–34 466 29.5 (2.8) 71.9
35–44 486 39.6 (2.9) 71.2
45–54 367 49.1 (2.8) 70.6
55–64 270 59.1 (2.7) 71.5
65–74 99 68.9 (2.9) 69.7
75–80 43 77.2 (1.8) 67.4
2008 18–19 80 18.5 (0.5) 76.3
20–24 208 21.9 (1.4) 71.6
25–34 389 29.6 (2.9) 69.4
35–44 417 39.7 (2.9) 63.8
45–54 353 49.1 (2.9) 70.8
55–64 220 59.0 (2.9) 71.8
65–74 100 68.5 (3.1) 71.0
75–80 34 77.2 (1.7) 82.4
2009 18–19 65 18.6 (0.5) 73.8
20–24 173 22.1 (1.4) 72.3
25–34 323 29.7 (2.9) 67.8
35–44 343 39.6 (2.8) 65.9
45–54 304 49.5 (2.9) 70.1
55–64 175 59.2 (2.8) 75.4
65–74 78 68.6 (2.8) 71.8
75–80 25 77.5 (1.8) 68.0
2010 18–19 64 18.6 (0.5) 70.3
20–24 197 21.9 (1.4) 68.5
25–34 348 29.3 (2.9) 67.8
35–44 394 39.7 (2.9) 66.5
45–54 358 49.1 (2.8) 68.7
55–64 225 59.2 (2.9) 71.1
65–74 99 68.7 (2.8) 68.7
75–80 30 77.2 (1.7) 76.7
2011 18–19 70 18.6 (0.5) 65.7
20–24 198 22.0 (1.4) 70.2
25–34 347 29.6 (2.9) 67.4
35–44 390 39.4 (2.9) 67.9
45–54 334 49.2 (2.9) 76.3
55–64 239 59.2 (2.9) 68.2
65–74 99 68.7 (2.9) 68.7
75–80 25 77.4 (1.6) 64.0
2012 18–19 58 18.6 (0.5) 74.1
20–24 183 21.8 (1.5) 72.7
25–34 317 29.6 (2.9) 67.2
35–44 323 39.6 (2.8) 64.7
45–54 321 49.2 (2.8) 70.1
55–64 206 59.1 (3.0) 72.3
65–74 98 68.5 (2.7) 60.2
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